首页 > 市场调查报告书 > 製药

以基因为基之药物开发

全球光学基因组图谱市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

市场调查报告书

商品编码

1421052

全球光学基因组图谱市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Optical Genome Mapping Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年01月01日 | 出版商:

Value Market Research | 英文 234 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球光学基因组图谱市场需求预计将从 2023 年的 119.07 万美元达到 2032 年近 1267.1 百万美元的市场规模，2024-2032 年研究期间复合CAGR为 30.05%。

光学基因组作图是一种基因组技术，可提供个体整个基因组的高解析度图谱。与读取核苷酸碱基序列的传统 DNA 定序方法不同，光学基因组作图涉及长 DNA 分子的直接可视化和分析。该技术利用先进的成像技术（例如萤光显微镜）来捕捉拉伸和标记 DNA 链的详细图像。

市场动态

在多种因素的推动下，光学基因组图谱市场正在经历显着成长。这项技术因其分析基因组结构变异的能力而脱颖而出，提供高解析度图谱来补充传统 DNA 定序。人们对了解结构变异在遗传性疾病和疾病中的作用的兴趣日益浓厚，推动了对光学基因组作图的需求。其在临床诊断中的应用，特别是在癌症研究和遗传易感性识别中的应用，有助于其在医疗保健领域的采用。影像技术的进步提高了光学基因组作图的可靠性，使其对广泛的基因组学应用更具吸引力。基因组学研究资金的增加、政府倡议以及基因组计画的激增进一步推动了这项技术的开发和采用。市场的扩张以及光学基因组图谱与更广泛的基因组学计划的整合受到技术开发商、研究机构和医疗保健组织之间的合作和伙伴关係的显着影响。该技术在基因组研究中的多功能性和互补作用使其成为寻求全面了解基因组结构的研究人员和临床医生的宝贵工具。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球光学基因组图谱市场的每个细分市场进行了包容性评估。光学基因组图谱产业的成长和趋势为这项研究提供了整体方法。

市场区隔

光学基因组图谱市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

仪器
耗材及试剂
软体
服务

按应用

结构变异检测
基因组组装
微生物菌株分型
其他的

按最终用户

生物技术和製药公司
临床实验室
学术研究机构
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲光学基因组图谱市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。光学基因组图谱市场的主要参与者包括 Bionano Genomics、Nucleome Informatics Private Limited、Praxis Genomics, LLC、SourceBio International Limited (Source BioScience)、MedGenome、INRAE (法国植物基因组资源中心 (CNRGV))、PerkinElmer (PerkinElmer Genomics) ， Genohub Inc.，Hofkens 实验室，塞尔巴。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：光学基因组图谱公司的竞争格局

光学基因组图谱市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

公司股份分析
市场集中度
Bionano Genomics

公司简介
公司收入
产品
最近的发展

Nucleome Informatics Private Limited

公司简介
公司收入
产品
最近的发展

Praxis Genomics LLC

公司简介
公司收入
产品
最近的发展

SourceBio International Limited (Source BioScience)

公司简介
公司收入
产品
最近的发展

MedGenome

公司简介
公司收入
产品
最近的发展

INRAE (French Plant Genomic Resources Center (CNRGV))

公司简介
公司收入
产品
最近的发展

PerkinElmer (PerkinElmer Genomics)

公司简介
公司收入
产品
最近的发展

Genohub Inc.

公司简介
公司收入
产品
最近的发展

Hofkens Lab

公司简介
公司收入
产品
最近的发展

Cerba

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112113361

The global demand for Optical Genome Mapping Market is presumed to reach the market size of nearly USD 1267.1 MN by 2032 from USD 119.07 MN in 2023 with a CAGR of 30.05% under the study period 2024 - 2032.

Optical genome mapping is a genomic technology that provides a high-resolution map of an individual's entire genome. Unlike traditional DNA sequencing methods, which read the sequence of nucleotide bases, optical genome mapping involves the direct visualization and analysis of long DNA molecules. This technique utilizes advanced imaging technologies, such as fluorescence microscopy, to capture detailed images of stretched and labeled DNA strands.

MARKET DYNAMICS

The Optical genome mapping market is experiencing significant growth driven by various factors. This technology stands out for its ability to analyze structural variations in the genome, offering a high-resolution map that complements traditional DNA sequencing. The rising interest in understanding the role of structural variations in genetic disorders and diseases propels the demand for Optical genome mapping. Its applications in clinical diagnostics, especially in cancer research and genetic predisposition identification, contribute to its adoption in the healthcare sector. Advancements in imaging technologies enhance the reliability of optical genome mapping, making it more attractive for a broad range of genomics applications. Increased funding for genomics research, government initiatives, and a surge in genomic projects further boost the development and adoption of this technology. The expansion of the market and the integration of optical genome mapping into broader genomics initiatives are significantly influenced by collaborations and partnerships among technology developers, research institutions, and healthcare organizations. The technology's versatility and complementary role in genomic studies position it as a valuable tool for researchers and clinicians seeking a comprehensive understanding of genomic architecture.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of optical genome mapping. The growth and trends of optical genome mapping industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the optical genome mapping market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Instruments
Consumables And Reagents
Software
Services

By Application

Structural Variant Detection
Genome Assembly
Microbial Strain Typing
Others

By End-User

Biotechnology And Pharmaceutical Companies
Clinical Laboratories
Academic Research Institutes
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Optical Genome Mapping market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Optical Genome Mapping market include Bionano Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, SourceBio International Limited (Source BioScience), MedGenome, INRAE (French Plant Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub Inc., Hofkens Lab, Cerba. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . OPTICAL GENOME MAPPING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL OPTICAL GENOME MAPPING MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Instruments Historic and Forecast Sales by Regions
5.5 Consumables and Reagents Historic and Forecast Sales by Regions
5.6 Software Historic and Forecast Sales by Regions
5.7 Services Historic and Forecast Sales by Regions

6 . GLOBAL OPTICAL GENOME MAPPING MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Structural Variant Detection Historic and Forecast Sales by Regions
6.5 Genome Assembly Historic and Forecast Sales by Regions
6.6 Microbial Strain Typing Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL OPTICAL GENOME MAPPING MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Biotechnology and Pharmaceutical Companies Historic and Forecast Sales by Regions
7.5 Clinical Laboratories Historic and Forecast Sales by Regions
7.6 Academic research institutes Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL OPTICAL GENOME MAPPING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE OPTICAL GENOME MAPPING COMPANIES

9.1. Optical Genome Mapping Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF OPTICAL GENOME MAPPING INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Bionano Genomics
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Nucleome Informatics Private Limited
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Praxis Genomics LLC
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. SourceBio International Limited (Source BioScience)
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. MedGenome
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. INRAE (French Plant Genomic Resources Center (CNRGV))
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. PerkinElmer (PerkinElmer Genomics)
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Genohub Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Hofkens Lab
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Cerba
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments